Greenwich Lifesciences Inc(GLSI)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GLSI Greenwich Lifesciences Inc

已收盘 04-29 16:00:00 EDT

21.60

-1.20

-5.26%

盘后21.59

-0.01-0.05%

19:41 EDT

最高22.64	最低21.25	成交量15.47万
今开22.64	昨收22.80	日振幅6.10%
总市值2.99亿	流通市值1.38亿	总股本1,385万
成交额337.70万	换手率2.43%	流通股本637.45万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"GLSI","market":"US","secType":"STK","nameCN":"Greenwich Lifesciences Inc","latestPrice":21.6,"timestamp":1777492800000,"preClose":22.8,"halted":0,"volume":154741,"hourTrading":{"tag":"盘后","latestPrice":21.59,"preClose":21.6,"latestTime":"19:41 EDT","volume":2614,"amount":57639.738,"timestamp":1777506110973,"change":-0.01,"changeRate":-0.000463,"amplitude":0.026366},"delay":0,"changeRate":-0.05263157894736839,"floatShares":6374500,"shares":13854539,"eps":-1.460569,"marketStatus":"已收盘","change":-1.2,"latestTime":"04-29 16:00:00 EDT","open":22.64,"high":22.64,"low":21.25,"amount":3377043.599145,"amplitude":0.060965,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.460569,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1777536000000},"marketStatusCode":5,"adr":0,"listingDate":1601006400000,"exchange":"NASDAQ","adjPreClose":22.8,"preHourTrading":{"tag":"盘前","latestPrice":23,"preClose":22.8,"latestTime":"09:26 EDT","volume":573,"amount":13223.433285000001,"timestamp":1777469170826,"change":0.2,"changeRate":0.008772,"amplitude":0.013158},"postHourTrading":{"tag":"盘后","latestPrice":21.59,"preClose":21.6,"latestTime":"19:41 EDT","volume":2614,"amount":57639.738,"timestamp":1777506110973,"change":-0.01,"changeRate":-0.000463,"amplitude":0.026366},"volumeRatio":1.715954},"requestUrl":"/m/hq/s/GLSI","defaultTab":"news","newsList":[{"id":"1106723359","title":"Greenwich Lifesciences公布Flamingo-01三期临床试验开放标签数据 亮相2026年AACR年会","url":"https://stock-news.laohu8.com/highlight/detail?id=1106723359","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1106723359?lang=zh_cn&edition=full","pubTime":"2026-04-20 18:00","pubTimestamp":1776679222,"startTime":"0","endTime":"0","summary":"格林尼治生命科学公司最新披露的Flamingo-01三期临床试验开放标签数据，在2026年美国癌症研究协会年会上正式发布。这项关键性研究数据展现了该公司在肿瘤免疫治疗领域的最新突破。\n临床数据显示，接受GP2肽段疫苗治疗的三阴性乳腺癌患者，在术后辅助治疗中表现出显著的免疫应答。该开放标签扩展研究纳入了已完成标准治疗的早期乳腺癌患者，通过监测GP2特异性T细胞反应评估疫苗疗效。\n研究人员采用ELISPOT检测法测定干扰素-γ分泌水平，发现疫苗接种组较对照组出现明显增强的细胞免疫反应。持续随访数据表明，这种免疫激活效应在强化接种后得以维持，为预防癌症复发提供了新的免疫治疗策略。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GLSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146410981","title":"Greenwich Lifesciences非HLA-A*02亚组初步数据：复发风险降低70-80%","url":"https://stock-news.laohu8.com/highlight/detail?id=1146410981","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146410981?lang=zh_cn&edition=full","pubTime":"2026-03-18 18:05","pubTimestamp":1773828353,"startTime":"0","endTime":"0","summary":"生物制药公司Greenwich Lifesciences Inc近日公布其核心免疫疗法GP2在乳腺癌辅助治疗中的最新分析结果。初步数据显示，在非HLA-A*02基因型患者亚组中，GP2治疗可将乳腺癌复发率显著降低70%-80%。这一数据来自IIb期临床试验的后续分析，涉及约160名已完成标准治疗的HER2/neu阳性乳腺癌患者。GP2是一种靶向HER2/neu蛋白的肽类免疫疗法，通过激活特异性T细胞攻击表达HER2的肿瘤细胞。GP2若在III期临床试验中验证疗效，有望成为首个专注于预防HER2阳性乳腺癌复发的免疫疗法。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLSI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100109826","title":"格林威治生命科学股价盘前飙升15%，其GLSI-100药物试验显示乳腺癌复发率降低","url":"https://stock-news.laohu8.com/highlight/detail?id=1100109826","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100109826?lang=zh_cn&edition=full","pubTime":"2026-03-17 18:59","pubTimestamp":1773745195,"startTime":"0","endTime":"0","summary":"格林威治生命科学公司股价在盘前交易中大幅跃升15%。这一强劲表现源于其核心候选药物GLSI-100的临床试验取得了积极结果。数据显示，该药物在降低乳腺癌复发率方面展现出显著潜力。\n市场对此消息反应热烈，投资者信心得到极大提振。新药研发的突破性进展，预示着公司在肿瘤治疗领域的重要突破，也为未来的商业化前景注入了强劲动力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLSI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144615957","title":"Greenwich Lifesciences公布Flamingo-01开放标签组复发率持续下降的最新数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1144615957","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1144615957?lang=zh_cn&edition=full","pubTime":"2026-03-17 18:01","pubTimestamp":1773741677,"startTime":"0","endTime":"0","summary":"Greenwich Lifesciences Inc（GLSI）近日发布了关于其Flamingo-01临床试验开放标签组的最新进展。数据显示，该组患者的癌症复发率呈现持续下降趋势，进一步验证了试验药物的潜在疗效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLSI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614084901","title":"Greenwich Lifesciences, Inc.盘中异动 早盘股价大涨5.53%报23.96美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614084901","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614084901?lang=zh_cn&edition=full","pubTime":"2026-02-24 22:43","pubTimestamp":1771944236,"startTime":"0","endTime":"0","summary":"北京时间2026年02月24日22时43分，Greenwich Lifesciences, Inc.股票出现异动，股价大幅上涨5.53%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体涨幅为0.03%。Greenwich Lifesciences, Inc.公司简介：Greenwich LifeSciences Inc 是一家临床阶段的生物制药公司，专注于其 III 期临床试验 Flamingo-01，该试验正在评估 GLSI-100，是一种预防乳腺癌复发的免疫疗法。GP2 GM-CSF 的组合称为 GLSI-100。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022422435697a6e0ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022422435697a6e0ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GLSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2611785970","title":"Greenwich Lifesciences, Inc.盘中异动 早盘股价大跌5.84%报26.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2611785970","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611785970?lang=zh_cn&edition=full","pubTime":"2026-02-13 00:11","pubTimestamp":1770912700,"startTime":"0","endTime":"0","summary":"北京时间2026年02月13日00时11分，Greenwich Lifesciences, Inc.股票出现波动，股价大幅下挫5.84%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体涨幅为0.61%。Greenwich Lifesciences, Inc.公司简介：Greenwich LifeSciences Inc 是一家临床阶段的生物制药公司，专注于其 III 期临床试验 Flamingo-01，该试验正在评估 GLSI-100，是一种预防乳腺癌复发的免疫疗法。GP2 GM-CSF 的组合称为 GLSI-100。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602130011409540f00b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602130011409540f00b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GLSI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610831389","title":"Greenwich Lifesciences, Inc.盘中异动 股价大跌5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610831389","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610831389?lang=zh_cn&edition=full","pubTime":"2026-02-11 02:58","pubTimestamp":1770749939,"startTime":"0","endTime":"0","summary":"北京时间2026年02月11日02时58分，Greenwich Lifesciences, Inc.股票出现波动，股价大幅跳水5.21%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体跌幅为0.32%。Greenwich Lifesciences, Inc.公司简介：Greenwich LifeSciences Inc 是一家临床阶段的生物制药公司，专注于其 III 期临床试验 Flamingo-01，该试验正在评估 GLSI-100，是一种预防乳腺癌复发的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211025859a494a37a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211025859a494a37a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GLSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607988200","title":"Greenwich Lifesciences, Inc.盘中异动 早盘急速拉升5.11%报30.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2607988200","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607988200?lang=zh_cn&edition=full","pubTime":"2026-01-29 23:11","pubTimestamp":1769699470,"startTime":"0","endTime":"0","summary":"北京时间2026年01月29日23时11分，Greenwich Lifesciences, Inc.股票出现波动，股价急速拉升5.11%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。Greenwich Lifesciences, Inc.公司简介：Greenwich LifeSciences Inc 是一家临床阶段的生物制药公司，专注于其 III 期临床试验 Flamingo-01，该试验正在评估 GLSI-100，是一种预防乳腺癌复发的免疫疗法。GP2 GM-CSF 的组合称为 GLSI-100。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129231110a465525e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129231110a465525e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GLSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105439760","title":"Greenwich Lifesciences盘前股价飙升近16% 获FDA批准乳腺癌试验物资供应","url":"https://stock-news.laohu8.com/highlight/detail?id=1105439760","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1105439760?lang=zh_cn&edition=full","pubTime":"2026-01-22 19:34","pubTimestamp":1769081696,"startTime":"0","endTime":"0","summary":"在FDA批准其乳腺癌试验所需物资供应后，Greenwich Lifesciences Inc（GLSI）股价在盘前交易中大幅跃升近16%。这一监管进展为该公司推进GP2乳腺癌免疫疗法三期临床试验扫清了关键障碍，标志着其在肿瘤治疗领域的重要突破。市场对此反应积极，投资者看好该疗法商业化前景，推动股价呈现强劲上涨态势。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLSI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603672866","title":"Greenwich Lifesciences, Inc.盘中异动 股价大涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603672866","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603672866?lang=zh_cn&edition=full","pubTime":"2026-01-14 23:20","pubTimestamp":1768404018,"startTime":"0","endTime":"0","summary":"北京时间2026年01月14日23时20分，Greenwich Lifesciences, Inc.股票出现波动，股价急速拉升5.10%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。Greenwich Lifesciences, Inc.公司简介：Greenwich LifeSciences Inc 是一家临床阶段的生物制药公司，专注于其 III 期临床试验 Flamingo-01，该试验正在评估 GLSI-100，是一种预防乳腺癌复发的免疫疗法。GP2 GM-CSF 的组合称为 GLSI-100。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114232018a4c3d5cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114232018a4c3d5cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GLSI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603542444","title":"Greenwich Lifesciences, Inc.盘中异动 大幅下挫5.17%报23.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603542444","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603542444?lang=zh_cn&edition=full","pubTime":"2026-01-12 22:36","pubTimestamp":1768228564,"startTime":"0","endTime":"0","summary":"北京时间2026年01月12日22时36分，Greenwich Lifesciences, Inc.股票出现异动，股价快速下挫5.17%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体跌幅为1.35%。Greenwich Lifesciences, Inc.公司简介：Greenwich LifeSciences Inc 是一家临床阶段的生物制药公司，专注于其 III 期临床试验 Flamingo-01，该试验正在评估 GLSI-100，是一种预防乳腺癌复发的免疫疗法。GP2 GM-CSF 的组合称为 GLSI-100。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011222360597a17640&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011222360597a17640&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GLSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601364086","title":"Greenwich Lifesciences, Inc.盘中异动 急速拉升5.11%报21.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601364086","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601364086?lang=zh_cn&edition=full","pubTime":"2026-01-07 22:49","pubTimestamp":1767797351,"startTime":"0","endTime":"0","summary":"北京时间2026年01月07日22时49分，Greenwich Lifesciences, Inc.股票出现波动，股价大幅拉升5.11%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体涨幅为1.79%。Greenwich Lifesciences, Inc.公司简介：Greenwich LifeSciences Inc 是一家临床阶段的生物制药公司，专注于其 III 期临床试验 Flamingo-01，该试验正在评估 GLSI-100，是一种预防乳腺癌复发的免疫疗法。GP2 GM-CSF 的组合称为 GLSI-100。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026010722491197a13383&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026010722491197a13383&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GLSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2600038865","title":"Greenwich Lifesciences, Inc.盘中异动 早盘股价大跌5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2600038865","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600038865?lang=zh_cn&edition=full","pubTime":"2025-12-31 22:35","pubTimestamp":1767191720,"startTime":"0","endTime":"0","summary":"北京时间2025年12月31日22时35分，Greenwich Lifesciences, Inc.股票出现波动，股价大幅下跌5.34%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体跌幅为0.15%。Greenwich Lifesciences, Inc.公司简介：Greenwich LifeSciences Inc 是一家临床阶段的生物制药公司，专注于其 III 期临床试验 Flamingo-01，该试验正在评估 GLSI-100，是一种预防乳腺癌复发的免疫疗法。GP2 GM-CSF 的组合称为 GLSI-100。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251231223521953be08f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251231223521953be08f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GLSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2592036219","title":"Greenwich Lifesciences, Inc.盘中异动 早盘股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592036219","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592036219?lang=zh_cn&edition=full","pubTime":"2025-12-17 22:40","pubTimestamp":1765982421,"startTime":"0","endTime":"0","summary":"北京时间2025年12月17日22时40分，Greenwich Lifesciences, Inc.股票出现异动，股价快速上涨5.00%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。Greenwich Lifesciences, Inc.公司简介：Greenwich LifeSciences Inc 是一家临床阶段的生物制药公司，专注于其 III 期临床试验 Flamingo-01，该试验正在评估 GLSI-100，是一种预防乳腺癌复发的免疫疗法。GP2 GM-CSF 的组合称为 GLSI-100。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217224021a6ae77c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217224021a6ae77c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GLSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518209140","title":"Greenwich Lifesciences, Inc.盘中异动 下午盘股价大跌5.04%报11.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518209140","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518209140?lang=zh_cn&edition=full","pubTime":"2025-03-11 02:37","pubTimestamp":1741631846,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日02时37分，Greenwich Lifesciences, Inc.股票出现波动，股价快速下挫5.04%。截至发稿，该股报11.49美元/股，成交量9322股，换手率0.07%，振幅5.21%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体涨幅为0.55%。Greenwich Lifesciences, Inc.公司简介：Greenwich lifessciences Inc 是一家临床阶段的生物制药公司，专注于开发 GP2，这是一种免疫疗法，用于预防已经接受过手术的患者乳腺癌复发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311023726964071c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311023726964071c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GLSI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517535164","title":"Greenwich Lifesciences, Inc.盘中异动 快速下挫5.44%报11.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517535164","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517535164?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:49","pubTimestamp":1741272542,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时49分，Greenwich Lifesciences, Inc.股票出现波动，股价急速下挫5.44%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体跌幅为0.67%。Greenwich Lifesciences, Inc.公司简介：Greenwich lifessciences Inc 是一家临床阶段的生物制药公司，专注于开发 GP2，这是一种免疫疗法，用于预防已经接受过手术的患者乳腺癌复发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306224903abeb7cb7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306224903abeb7cb7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GLSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516301329","title":"Greenwich Lifesciences, Inc.盘中异动 股价大涨5.29%报12.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516301329","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516301329?lang=zh_cn&edition=full","pubTime":"2025-03-01 04:53","pubTimestamp":1740775997,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日04时53分，Greenwich Lifesciences, Inc.股票出现波动，股价急速上涨5.29%。截至发稿，该股报12.15美元/股，成交量1.4511万股，换手率0.11%，振幅4.85%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体涨幅为0.79%。Greenwich Lifesciences, Inc.公司简介：Greenwich lifessciences Inc 是一家临床阶段的生物制药公司，专注于开发 GP2，这是一种免疫疗法，用于预防已经接受过手术的患者乳腺癌复发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503010453189896c7eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503010453189896c7eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GLSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506306788","title":"Greenwich Lifesciences, Inc.盘中异动 早盘股价大涨5.04%报13.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506306788","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506306788?lang=zh_cn&edition=full","pubTime":"2025-01-27 23:24","pubTimestamp":1737991477,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日23时24分，Greenwich Lifesciences, Inc.股票出现异动，股价急速上涨5.04%。截至发稿，该股报13.75美元/股，成交量1.1902万股，换手率0.09%，振幅4.20%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体涨幅为1.32%。Greenwich Lifesciences, Inc.公司简介：Greenwich lifessciences Inc 是一家临床阶段的生物制药公司，专注于开发 GP2，这是一种免疫疗法，用于预防已经接受过手术的患者乳腺癌复发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127232437abba6aed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127232437abba6aed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GLSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505720299","title":"Greenwich Lifesciences, Inc.盘中异动 早盘股价大涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505720299","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505720299?lang=zh_cn&edition=full","pubTime":"2025-01-23 00:12","pubTimestamp":1737562326,"startTime":"0","endTime":"0","summary":"北京时间2025年01月23日00时12分，Greenwich Lifesciences, Inc.股票出现异动，股价大幅上涨5.26%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。Greenwich Lifesciences, Inc.公司简介：Greenwich lifessciences Inc 是一家临床阶段的生物制药公司，专注于开发 GP2，这是一种免疫疗法，用于预防已经接受过手术的患者乳腺癌复发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123001207a22bc844&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123001207a22bc844&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GLSI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505191202","title":"Greenwich Lifesciences, Inc.盘中异动 股价大跌5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505191202","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505191202?lang=zh_cn&edition=full","pubTime":"2025-01-22 02:03","pubTimestamp":1737482583,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日02时03分，Greenwich Lifesciences, Inc.股票出现波动，股价大幅下挫5.28%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体涨幅为2.22%。Greenwich Lifesciences, Inc.公司简介：Greenwich lifessciences Inc 是一家临床阶段的生物制药公司，专注于开发 GP2，这是一种免疫疗法，用于预防已经接受过手术的患者乳腺癌复发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122020303960bddc1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122020303960bddc1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GLSI"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.greenwichlifesciences.com","stockEarnings":[{"period":"1week","weight":-0.0048},{"period":"1month","weight":0.021},{"period":"3month","weight":-0.2025},{"period":"6month","weight":1.481},{"period":"1year","weight":1.2709},{"period":"ytd","weight":0.0852}],"compareEarnings":[{"period":"1week","weight":0.0108},{"period":"1month","weight":0.1224},{"period":"3month","weight":0.0234},{"period":"6month","weight":0.0469},{"period":"1year","weight":0.292},{"period":"ytd","weight":0.0437}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Greenwich LifeSciences, Inc.成立于2006年8月29日，是特拉华州的一家公司。该公司是一家生物制药公司，正在开发GP2，这是一种旨在预防术后乳腺癌复发的免疫疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.082906},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.00815},{"month":3,"riseRate":0.5,"avgChangeRate":0.044197},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.147606},{"month":5,"riseRate":0.4,"avgChangeRate":-0.034914},{"month":6,"riseRate":0.6,"avgChangeRate":0.055327},{"month":7,"riseRate":0.2,"avgChangeRate":-0.014519},{"month":8,"riseRate":0.6,"avgChangeRate":0.020316},{"month":9,"riseRate":0.2,"avgChangeRate":-0.041624},{"month":10,"riseRate":0,"avgChangeRate":-0.089083},{"month":11,"riseRate":0.666667,"avgChangeRate":0.225666},{"month":12,"riseRate":0.5,"avgChangeRate":1.139783}],"exchange":"NASDAQ","name":"Greenwich Lifesciences Inc","nameEN":"Greenwich Lifesciences Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Greenwich Lifesciences Inc(GLSI)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Greenwich Lifesciences Inc(GLSI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Greenwich Lifesciences Inc,GLSI,Greenwich Lifesciences Inc股票,Greenwich Lifesciences Inc股票老虎,Greenwich Lifesciences Inc股票老虎国际,Greenwich Lifesciences Inc行情,Greenwich Lifesciences Inc股票行情,Greenwich Lifesciences Inc股价,Greenwich Lifesciences Inc股市,Greenwich Lifesciences Inc股票价格,Greenwich Lifesciences Inc股票交易,Greenwich Lifesciences Inc股票购买,Greenwich Lifesciences Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Greenwich Lifesciences Inc(GLSI)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Greenwich Lifesciences Inc(GLSI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}